Study of a new hair loss treatment for men
Treatments studied
Part of Skin clinical trials.
This study tests an experimental medication (CKD-843) for men with male pattern baldness. It aims to see if the treatment is safe and effective for regrowing hair.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 50 years old.
- You have been diagnosed with male pattern baldness (androgenetic alopecia).
- You do not have other types of hair loss or scalp conditions like severe dandruff or psoriasis.
- You are generally healthy without significant liver, thyroid, or mental health issues.
- You agree to use contraception during the study and for 6 months after your last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a topical solution with dutasteride can help regrow hair in men with androgenetic alopecia (male pattern baldness). It might slow hair loss and promote new growth, giving a non-invasive option.
This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.
This study tests whether a dietary supplement helps hair growth in men with mild to moderate male pattern baldness. It lasts 6 months, and you will not know if you are getting the real supplement or a placebo.
This Phase 3 study tests whether a specific hair lotion works and is safe for men with male pattern hair loss. It also checks that results are consistent while you keep similar hair care and avoid certain other hair-loss treatments.
This study tests two new topical treatments for hereditary hair loss. It may help you regrow hair or slow further thinning.
This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.
Hear when a new Androgenetic Alopecia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.